T
TEVA icon

TOBAM’s Teva Pharmaceuticals TEVA Stock Holding History

TOBAM’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-362,069
Closed -$3.78M – 396
2023
Q4 		$3.78M Sell
362,069
-23,827
-6% -$222K 0.33% 59
2023
Q3 		$3.94M Buy
385,896
+382,559
+11,464% +$3.56M 0.32% 60
2023
Q2 		$25K Buy
+3,337
New +$27.1K ﹤0.01% 358
2020
Q2 		– Sell
-102,004
Closed -$916K – 169
2020
Q1 		$916K Buy
+102,004
New +$1.05M 0.07% 103
2018
Q4 		– Sell
-127,176
Closed -$2.74M – 168
2018
Q3 		$2.74M Sell
127,176
-249,451
-66% -$5.79M 0.12% 110
2018
Q2 		$9.16M Sell
376,627
-123,881
-25% -$2.53M 0.38% 75
2018
Q1 		$8.55M Sell
500,508
-371,099
-43% -$7.25M 0.35% 80
2017
Q4 		$16.5M Buy
871,607
+348,762
+67% +$5.25M 0.71% 58
2017
Q3 		$9.2M Buy
522,845
+143,497
+38% +$3.23M 0.35% 75
2017
Q2 		$12.6M Sell
379,348
-245,966
-39% -$7.61M 0.47% 62
2017
Q1 		$20.1M Buy
625,314
+159,218
+34% +$5.43M 0.77% 48
2016
Q4 		$16.9M Sell
466,096
-78,726
-14% -$3.14M 0.69% 52
2016
Q3 		$25.1M Sell
544,822
-210,025
-28% -$11M 0.9% 45
2016
Q2 		$37.9M Buy
754,847
+174,101
+30% +$9.27M 1.52% 30
2016
Q1 		$31.1M Buy
580,746
+351,854
+154% +$20.6M 1.22% 32
2015
Q4 		$15M Buy
+228,892
New +$14.1M 0.65% 52

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

TOBAM's TEVA Position: Q1 2024 in Review

TOBAM sold out of Teva Pharmaceuticals (TEVA) in Q1 2024, closing a stake of 362,069 shares — an estimated $3.78M sold.

TOBAM first reported a position in TEVA in Q4 2015 and held it in 16 quarters. The position peaked at $37.9M in Q2 2016. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • TOBAM reported no remaining Teva Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • TOBAM sold 362,069 Teva Pharmaceuticals shares in Q1 2024, an estimated $3.78M.
  • TOBAM first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 16 quarters.
  • TOBAM's Teva Pharmaceuticals position peaked at $37.9M in Q2 2016.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on TOBAM's 13F filing for Q1 2024, filed 2 May 2024.